Skip to main content
. 2022 Nov 23;13:1027648. doi: 10.3389/fphar.2022.1027648

TABLE 1.

Baseline characteristics.

200 mg BID (n = 10) 300 mg BID (n = 10) 400 mg BID (n = 10) 500 mg BID (n = 10) SHR7280 total(n = 40) Placebo (n = 8)
Age, years 32.7 ± 9.5 30.7 ± 9.3 32.7 ± 6.5 34.1 ± 5.5 32.6 ± 7.7 35.9 ± 3.4
BMI, kg/m2 22.8 ± 2.4 23.0 ± 3.1 22.4 ± 3.4 24.0 ± 1.7 23.1 ± 2.7 24.0 ± 2.9
Height, cm 160.2 ± 6.9 159.3 ± 6.3 160.8 ± 4.0 160.9 ± 5.4 160.3 ± 5.6 159.4 ± 7.4
Weight, kg 58.7 ± 8.8 58.3 ± 6.8 57.9 ± 9.6 62.1 ± 4.1 59.3 ± 7.5 60.8 ± 7.2

Data are mean ± SD.